Literature DB >> 15665080

A cascade of cytokines mediates mechanical inflammatory hypernociception in mice.

T M Cunha1, W A Verri, J S Silva, S Poole, F Q Cunha, S H Ferreira.   

Abstract

The hypernociceptive effects of cytokines [TNF-alpha, keratinocyte-derived chemokine (KC), and IL-1beta] and their participation in carrageenan (Cg)-induced inflammatory hypernociception in mice were investigated. Nociceptor sensitization (hypernociception) was quantified with an electronic version of the von Frey filament test in WT and TNF receptor type 1 knockout mice (TNF-R1-/-). TNF-alpha-induced hypernociception was abolished in TNF-R1-/- mice, partially inhibited by pretreatment with IL-1 receptor antagonist (IL-1ra) or indomethacin and unaffected by Ab against KC (AbKC) or guanethidine. IL-1ra and indomethacin pretreatment strongly inhibited the hypernociception induced by IL-1beta, which was not altered by AbKC or guanethidine or by knocking out TNF-R1. KC-induced hypernociception was abolished by AbKC, inhibited by pretreatment with indomethacin plus guanethidine, and partially inhibited by IL-1ra, indomethacin, or guanethidine. In contrast, KC-induced hypernociception was not altered by knocking out TNF-R1. Cg-induced hypernociception was abolished by administration of indomethacin plus guanethidine, diminished in TNF-R1-/- mice, and partially inhibited in WT mice pretreated with AbKC, IL-1ra, indomethacin, or guanethidine. TNF-alpha, KC, and IL-1beta concentrations were elevated in the skin of Cg-injected paws. The TNF-alpha and KC concentrations rose concomitantly and peaked before that of IL-1beta. In mice, the cytokine cascade begins with the release of TNF-alpha (acting on TNF-R1 receptor) and KC, which stimulate the release of IL-1beta. As in rats, the final mediators of this cascade were prostaglandins released by IL-1beta and sympathetic amines released by KC. These results extend to mice the concept that the release of primary mediators responsible for hypernociception is preceded by a cascade of cytokines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665080      PMCID: PMC547882          DOI: 10.1073/pnas.0409225102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

Review 1.  Molecular mechanisms of nociception.

Authors:  D Julius; A I Basbaum
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

Review 2.  Animal models of nociception.

Authors:  D Le Bars; M Gozariu; S W Cadden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 25.468

Review 3.  Peripheral hyperalgesic cytokines.

Authors:  Fernando Q Cunha; Sérgio H Ferreira
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

4.  Activation of presynaptic NMDA receptors coupled to NaV1.8-resistant sodium channel C-fibers causes retrograde mechanical nociceptor sensitization.

Authors:  Carlos Amilcar Parada; Gustavo Gameiro Vivancos; Claudia Herrera Tambeli; Fernando de Queiróz Cunha; Sérgio Henrique Ferreira
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-14       Impact factor: 11.205

5.  The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation.

Authors:  B Safieh-Garabedian; S Poole; J J Haddad; C A Massaad; S J Jabbur; N E Saadé
Journal:  Neuropharmacology       Date:  2002-05       Impact factor: 5.250

6.  The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization.

Authors:  C R Bozic; N P Gerard; C von Uexkull-Guldenband; L F Kolakowski; M J Conklyn; R Breslow; H J Showell; C Gerard
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

Review 7.  Cytokines and fever.

Authors:  Bruno Conti; Iustin Tabarean; Cristina Andrei; Tamas Bartfai
Journal:  Front Biosci       Date:  2004-05-01

8.  Electromotive administration of guanethidine for treatment of reflex sympathetic dystrophy: a pilot study in eight patients.

Authors:  C Bonezzi; D Miotti; R Bettaglio; R Stephen
Journal:  J Pain Symptom Manage       Date:  1994-01       Impact factor: 3.612

Review 9.  The pathophysiological role of cytokines.

Authors:  Stephen John Hopkins
Journal:  Leg Med (Tokyo)       Date:  2003-03       Impact factor: 1.376

10.  Cytokine-induced neutrophil chemoattractant 1 (CINC-1) mediates the sympathetic component of inflammatory mechanical hypersensitivitiy in rats.

Authors:  Berenice B Lorenzetti; Fabiane H Veiga; Claudio A Canetti; Stephen Poole; Fernando Q Cunha; Sérgio H Ferreira
Journal:  Eur Cytokine Netw       Date:  2002 Oct-Dec       Impact factor: 2.737

View more
  145 in total

1.  Gastroprotective activity of carvacrol on experimentally induced gastric lesions in rodents.

Authors:  Irisdalva S Oliveira; Francilene V da Silva; Ana Flávia S C Viana; Márcio R V dos Santos; Lucindo J Quintans-Júnior; Maria do Carmo C Martins; Paulo H M Nunes; Francisco de A Oliveira; Rita de C M Oliveira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-06-28       Impact factor: 3.000

2.  A p38 mitogen-activated protein kinase-dependent mechanism of disinhibition in spinal synaptic transmission induced by tumor necrosis factor-alpha.

Authors:  Haijun Zhang; Hui Nei; Patrick M Dougherty
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

3.  Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha.

Authors:  Xiaochun Jin; Robert W Gereau
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

4.  Proposal to use pentoxifylline and Lyprinol therapy for chronic inflammatory diseases.

Authors:  S H Ferreira
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

Review 5.  Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

Authors:  Xiao-Min Wang; Tanya J Lehky; Joanna M Brell; Susan G Dorsey
Journal:  Cytokine       Date:  2012-04-24       Impact factor: 3.861

6.  The α7 nicotinic ACh receptor agonist compound B and positive allosteric modulator PNU-120596 both alleviate inflammatory hyperalgesia and cytokine release in the rat.

Authors:  G Munro; Rr Hansen; Hk Erichsen; Db Timmermann; Jk Christensen; Hh Hansen
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

7.  Role of inflammation gene polymorphisms on pain severity in lung cancer patients.

Authors:  Cielito C Reyes-Gibby; Margaret R Spitz; Sriram Yennurajalingam; Michael Swartz; Jian Gu; Xifeng Wu; Eduardo Bruera; Sanjay Shete
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-22       Impact factor: 4.254

8.  The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care.

Authors:  Cielito C Reyes-Gibby; Badi El Osta; Margaret R Spitz; Henrique Parsons; Razelle Kurzrock; Xifeng Wu; Sanjay Shete; Eduardo Bruera
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

9.  Urotensin receptors as a new target for CLP induced septic lung injury in mice.

Authors:  Elif Cadirci; Rustem Anil Ugan; Busra Dincer; Betul Gundogdu; Irfan Cinar; Erol Akpinar; Zekai Halici
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-24       Impact factor: 3.000

10.  The leguminous lectin of Lonchocarpus araripensis promotes antinociception via mechanisms that include neuronal inhibition of Na(+) currents.

Authors:  Renata Morais Ferreira Amorim; Alana Freitas Pires; Tiago Dos Santos-Nascimento; Benildo S Cavada; Kyria Santiago do Nascimento; João Batista Cajazeiras; José Henrique Leal-Cardoso; Mário Rogério Lima Mota; Ana Maria S Assreuy
Journal:  Inflamm Res       Date:  2016-05-18       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.